title: Antibacterial therapy: problems and promises, Part I.
abstract: Agents approved for clinical use in the past five years and others most likely to be available in the near future are evaluated in this two-part review. This installment is devoted entirely to the beta-lactam antibiotics--penicillins, cephalosporins, monobactams, and carbapenems. There are more similarities than differences among them, but the variations give each agent a range of appropriate uses.
authors.affiliation: Columbia University College of Physicians and Surgeons, New York.
authors.forename: H C
authors.initials: HC
authors.lastname: Neu
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D015780:Carbapenems / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D006801:Humans; D008997:Monobactams / Q000627:therapeutic use; D065093:beta-Lactamase Inhibitors
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems; D002511:Cephalosporins; D008997:Monobactams; D065093:beta-Lactamase Inhibitors